WASHINGTON, D.C. (Monday, March 22, 2010) - U.S. Food and Drug Administration (FDA) Commissioner Margaret Hamburg will be a featured speaker at the 2010 BIO International Convention being held May 3-6 in Chicago. She will headline the FDA Town Hall and speak at a session on the Obama Administration’s bioscience and biosecurity priorities.
“I look forward to hearing Commissioner Hamburg’s insights into the direction of regulatory policy under the Obama Administration, as well as her views on the challenges, needs and priorities at the FDA. Her remarks will be invaluable to attendees as they work to navigate FDA approvals for new therapies and products,” said BIO President and CEO Jim Greenwood.
During the May 5 FDA Town Hall (10:00 a.m. – 11:30 a.m.), Commissioner Hamburg will discuss topics such as preparations for PDUFA V (Prescription Drug User Fee Act), drug safety and transparency initiatives and other key FDA organizational and policy developments. Additionally, Commissioner Hamburg will participate in a May 5 (8:00 a.m. – 9:00 a.m.) panel discussion entitled, “Bioscience and Biosecurity Priorities of the Obama Administration.” During the event, she will discuss strategies for advancing the benefits of the life sciences, improving U.S. and global biosecurity and addressing challenges posed by life sciences research.
Other members of the Obama Administration who will participate in the 2010 BIO International Convention include:
David Kappos, Director of the U.S. Patent Office and Under Secretary of Commerce for Intellectual Property, who will speak at the May 3 intellectual property super session, entitled “Leveraging IP to Spur Global Biotechnology Innovation, Investment and Jobs,” which will examine the role that intellectual property systems play in attracting biotech investment and how some countries are successfully leveraging their patent policies to foster economic growth.
Regina Benjamin, US Surgeon General, will deliver the keynote address at a May 3 Diversity in Biotechnology Summit taking place during the Convention.
For more information on the program, please visit http://convention.bio.org/program/
The BIO International Convention helps to support the association’s programs and initiatives. BIO works throughout the year to create a policy environment that enables the industry to continue to fulfill its vision of bettering the world through biotechnology innovation. For more information on the global event for biotechnology, including program, registration, and housing information, please visit http://convention.bio.org/
Upcoming BIO Events
BIO Intellectual Property Counsels Spring Conference and Committee Meeting
April 19-21, 2010
New Orleans, LA
Partnering for Global Health
May 3, 2010
McCormick Place Convention Center
BIO International Convention
May 3-6, 2010
McCormick Place Convention Center
2010 BIO Human Resources Conference
May 4-7, 2010
World Congress on Industrial Biotechnology and Bioprocessing
June 27-30, 2010
September 21 - 22, 2010
BIO’s Livestock Biotechnology Summit
September 28-30, 2010,
Sioux Falls, SD
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.